We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medcaw Investments Plc | LSE:MCI | London | Ordinary Share | GB00BM8SQP62 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.25 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 0 | -194k | -0.0113 | -3.76 | 728.11k |
From Jun 2022 to Jun 2024
Medcaw Investments Plc
(“Medcaw Investments” or the “Company”)
Board Role Changes
Medcaw Investments Plc (LSE:MCI), a special purpose acquisition vehicle, announces that it has re-structured its internal board roles and responsibilities as follows:-
Non-Executive Director Marcus Yeoman will become Non-Executive Chairman. Executive Chairman Sarah Cope will become a Non-Executive Director. Non-Executive Director Charles Wood will become Executive Director.
The persons who arranged the release of this information are the Directors of the Company.
*** ENDS ***
Enquiries:
Medcaw Investments Plc info@medcaw-invest.com
Marcus Yeoman
Zeus Capital Ltd 44 203 829 5000
Alexandra Campbell-Harris
Copyright l 17 PR Newswire
1 Year Medcaw Investments Chart |
1 Month Medcaw Investments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
